Restoration of TGF-β regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells

Biochemical and Biophysical Research Communications

Volumn 294, Issue 5, 2002, Pages 1079-1086

  Xu, Guoxiong ^a   Chakraborty, Chandan ^a   Lala, Peeyush K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Choriocarcinoma; Signaling pathway; Smad; TGF ; Trophoblast; Tumor progression

Indexed keywords

CANCER GROWTH FACTOR; COMPLEMENTARY DNA; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN SUBUNIT; SMAD3 PROTEIN; UROKINASE;

ARTICLE; CARCINOMA CELL; CELL INVASION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN SECRETION;

CELL LINE; CHORIOCARCINOMA; DNA-BINDING PROTEINS; FEMALE; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY; RNA, MESSENGER; RNA, NEOPLASM; SMAD3 PROTEIN; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TROPHOBLASTS; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR; UTERINE NEOPLASMS;

EID: 0036288681     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00605-8     Document Type: Article

References (42)

1. Mechanism of control of trophoblast invasion in situ
2. Extravillous trophoblast in the human placenta. A review
3. Characterization of pure human first-trimester cytotrophoblast cells in long-term culture: Growth pattern, markers and hormone production
4. Localization of transforming growth factor-β at the human fetal-maternal interface: Role in trophoblast growth and differentiation
5. Functional role of cell surface integrins on human trophoblast cell migration: Regulation by TGF-β, IGF-II and IGFBP-1
6. Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells
7. Mechanisms of trophoblast invasiveness and their control: The role of proteases and protease inhibitors
8. Establishment and characterization of first trimester human trophoblast cells with extended life span
9. TGFB-responsive human trophoblast-derived cell lines
10. Resistance of malignant trophoblast cells to both anti-proliferation and anti-invasive effects of transforming growth factor-β
11. Physiological actions and clinical applications of transforming growth factor-β (TGF-β)
12. TGF-β signal transduction
13. TGF-β signaling from receptors to the nucleus
14. Controlling TGF-β signalling
15. The transforming growth factor-beta family
16. Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression
17. Acquisition of TGF-β1 resistance: An important progression factor in human renal cell carcinoma
18. Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells
19. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β
20. Mutations increasing autoinhibition inactivate tumor suppressors Smad2 and Smad4
21. Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers
22. Expression of TGF-β signaling genes in the normal, premalignant, and malignant human trophoblast: Loss of Smad3 in choriocarcinoma cells
23. Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue
24. Director binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator-type 1 gene
25. Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: Interactions of promoter DNA, transcription factor muE3, and Smad proteins
26. Characteristics of trophoblast cells migrating from first trimester chorionic villus explants and propagated in culture
27. Susceptibility of MHC class I expressing extravillous trophoblast cell lines to killing by natural killer cells
28. Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-β-induced physical and functional interactions between Smads and Sp1
29. Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction
30. Dominant-negative Smad3 interferes with transcriptional activation by multiple agonists
31. Receptor-associated Mad homologues synergize as effectors of the TGF-β response
32. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3
33. TGF-β signaling by Smad proteins
34. Targeted mutations of transforming growth factor-β genes reveal important roles in mouse development and adult homeostasis
35. Smad3 mutant mice develop metastatic colorectal cancer
36. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator
37. Urokinase receptor and integrin partnership: Coordination of signaling for cell adhesion, migration and growth
38. The activation of prourokinase by plasma kallikrein and its inactivation by thrombin
39. Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer
40. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3)
41. Metalloproteases and urokinase in angiogenesis and tumor progression
42. Expression of urokinase receptors by human trophoblast. A histochemical and ultrastructural analysis